| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |